These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6124137)

  • 21. Emergency psychiatry: extrapyramidal side effects in the psychiatric emergency service.
    Kamin J; Manwani S; Hughes D
    Psychiatr Serv; 2000 Mar; 51(3):287-9. PubMed ID: 10686232
    [No Abstract]   [Full Text] [Related]  

  • 22. Vulnerability to extrapyramidal side effects.
    Van Putten T
    Clin Neuropharmacol; 1983; 6 Suppl 1():S27-34. PubMed ID: 6139164
    [No Abstract]   [Full Text] [Related]  

  • 23. Calcium therapy for neuroleptic-induced extrapyramidal symptoms.
    Jancar J
    Br J Psychiatry; 1988 Aug; 153():256-7. PubMed ID: 2908237
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
    McClelland HA
    Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
    [No Abstract]   [Full Text] [Related]  

  • 25. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 26. Fluphenazine-induced extrapyramidal side effects in a horse.
    Brashier M
    Vet Clin North Am Equine Pract; 2006 Apr; 22(1):e37-45. PubMed ID: 16627093
    [No Abstract]   [Full Text] [Related]  

  • 27. Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.
    Malik T; Hasan S; Pervez S; Fatima T; Haleem DJ
    Neurochem Res; 2016 Dec; 41(12):3386-3398. PubMed ID: 27752803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs.
    McEvoy JP
    J Clin Psychopharmacol; 1983 Oct; 3(5):288-302. PubMed ID: 6138370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticholinergics to treat antipsychotic-induced extrapyramidal symptoms: Time to avoid this practice.
    Koola MM
    Asian J Psychiatr; 2018 Jan; 31():100-101. PubMed ID: 29454175
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced extrapyramidal disorders - a neuropsychiatric interface.
    Goetz CG; Klawans HL
    J Clin Psychopharmacol; 1981 Sep; 1(5):297-303. PubMed ID: 6120959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute-onset extrapyramidal syndromes caused by drugs].
    Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G
    Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition and treatment of rabbit syndrome, an uncommon complication of neuroleptic therapies.
    Todd R; Lippmann S; Manshadi M; Chang A
    Am J Psychiatry; 1983 Nov; 140(11):1519-20. PubMed ID: 6137964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Iatrogenic extrapyramidal disorders].
    Ludin HP
    Schweiz Med Wochenschr; 1990 Jun; 120(23):855-8. PubMed ID: 1972812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of piracetam on extrapyramidal side effects induced by neuroleptic drugs.
    Kabes J; Sikora J; Pisvejc J; Hanzlicek L; Skondia V
    Int Pharmacopsychiatry; 1982; 17(3):185-92. PubMed ID: 6128331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study.
    Weiden PJ; Mann JJ; Haas G; Mattson M; Frances A
    Am J Psychiatry; 1987 Sep; 144(9):1148-53. PubMed ID: 2888321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled trial of amantadine in drug-induced extrapyramidal disorders.
    DiMascio A; Bernardo DL; Greenblatt DJ; Marder JE
    Psychopharmacol Bull; 1977 Jul; 13(3):31-3. PubMed ID: 18755
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroleptic associated extrapyramidal symptoms.
    Maurer I; Zierz S; Möller HJ; Jerusalem F
    Br J Psychiatry; 1995 Oct; 167(4):551-2. PubMed ID: 8829733
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current status of our knowledge of the neurotropic side effects of neuroleptic drugs].
    Sabbatini F; Pinessi L; Gentile S; De Mattei M; Portaleone P
    Minerva Psichiatr; 1983; 24(4):145-53. PubMed ID: 6145083
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug-induced movement disorders].
    Takahashi A; Murasaki M
    Nihon Rinsho; 1993 Nov; 51(11):2929-34. PubMed ID: 7903986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.